Group 1: Financial Performance - The company expects a significant turnaround in 2025, with a substantial increase in net profit and net profit excluding non-recurring items compared to 2024, driven by international market expansion and cost control measures [2][3] - The overall operating costs were effectively controlled in 2025, with total expenses significantly reduced compared to the same period in 2024 [3] Group 2: Market Expansion - The company has made breakthroughs in overseas markets, particularly in Southeast Asia, the Middle East, and the Americas, leading to a notable increase in the proportion of international business in overall operations [2][4] - The international sales and service team has expanded, establishing localized sales and service points in over 20 key countries and regions [4] Group 3: Product Development and Innovation - The company has consistently focused on technological innovation, with R&D investment among the highest in the industry, launching new products such as continuous BFS and fully automated inspection machines [7] - Future strategies will continue to prioritize dual advancements in product technology and manufacturing technology, enhancing overall solution capabilities for clients in the pharmaceutical industry [7] Group 4: Strategic Outlook for 2026 - The company aims to further expand its overseas market presence, capitalizing on the growth and high-end transformation trends in the domestic pharmaceutical equipment industry [8] - Management strategies will focus on quality improvement and efficiency enhancement through smart manufacturing and cost control measures [8]

Company Overview - Hangzhou Heshun Technology Co., Ltd. was established in 2003, focusing on the R&D, production, and sales of differentiated, functional biaxially oriented polyester (BOPET) films [2] - The company produces various specifications and models of polyester film products, including color optical base films, functional films, and transparent films, applicable in consumer electronics and automotive sectors [2] - Future plans include expanding product series and application fields while exploring new materials, particularly in high-performance carbon fiber projects for sustainable development [2] BOPET Film Business - The BOPET film business is gradually improving, with several high-value-added new products developed and ready for sampling [3] - Performance improvement requires time, and impairment provisions from fundraising projects may impact current profits [3] Carbon Fiber Project - The carbon fiber project aims to enter a market dominated by a few companies, with high prices and concentrated supply [4] - The strategic goal is to develop and industrialize high-performance carbon fiber, creating synergy with existing BOPET film operations to enhance R&D and manufacturing capabilities [4] Strategic Planning - The company maintains a "differentiated, functional" positioning, focusing on high-end optical film production for short-term performance and high-performance carbon fiber for long-term growth [4] - Key applications include consumer electronics, new energy vehicles, and high-end equipment, establishing a dual-driven development model [4] - Short-term strategies involve deepening optical film business and optimizing product quality, while long-term strategies focus on scaling carbon fiber production and expanding into high-end applications [4] Target Customers for Carbon Fiber - Future customers for carbon fiber products are high-end enterprises in aerospace, high-end equipment manufacturing, and industrial applications [5] - The company will actively engage with potential clients and advance product sampling and performance validation [5] Equity Incentive Plans - The company will consider market conditions, development strategies, and shareholder interests when evaluating equity incentive plans [6]

Group 1: Company Overview - The company is involved in various mining projects, including the 460 Highland Copper-Molybdenum Mine and the Miaohuang Copper-Lead-Zinc-Silver Mine [1][3][6] - The company has a stable cash flow and plans to finance mining construction and acquisitions through self-funding and potential financing from financial institutions [3] Group 2: Production Estimates - The 460 Highland Copper-Molybdenum Mine's production capacity will be determined after obtaining the necessary safety production license [1] - The expected annual production scale for the Miaohuang Copper-Lead-Zinc-Silver Mine is 660,000 tons, with copper metal grade at 1.68%, lead metal grade at 2.66%, zinc metal grade at 2.40%, and silver metal grade at 83.75 grams per ton [6] Group 3: Capital Expenditure Plans - Future capital expenditures will focus on the development of multiple mining projects, including the Deyun Mining Bayannaoer Silver Polymetallic Mine and the 460 Highland Copper-Molybdenum Mine [3] - The company aims to enhance production management and explore new mineral resources through acquisitions [3] Group 4: Operational Challenges - Cold weather may temporarily halt operations at the 460 Highland Mine, with an estimated 330 effective working days per year [2] - The production cost for Honglin Mining is currently indeterminate due to various influencing factors, including safety requirements and the simplicity of the ore processing [5]

Group 1: Investor Relations Activity Overview - The investor relations activity was conducted on January 26, 2026, at the company's headquarters [2] - The event involved one investor from Great Wall Securities, Mr. Guo Qinglong [2] Group 2: Main Discussion Points - Investors engaged in discussions regarding industry conditions, the company's business model, product structure, and gross margin [2] - The company ensured compliance with information disclosure regulations, maintaining the accuracy and completeness of the information shared [2] Group 3: Compliance and Documentation - The company adhered to its information disclosure management system, preventing any leakage of undisclosed significant information [2] - Investors participating in the on-site survey signed a commitment letter as required by the Shenzhen Stock Exchange [2]

Company Overview - The history of Guoji Precision Engineering dates back to 1958 with the establishment of the Luoyang Bearing Research Institute and Zhengzhou Abrasives Research Institute, and it was listed on the Shenzhen Stock Exchange in 2005 [2][3] - The company focuses on precision manufacturing, driven by technological innovation, providing key products, technologies, and services that meet national strategic needs [2][3] Business Segments and Applications - Guoji Precision operates in five major sectors: new materials, basic components, machine tools, high-end equipment, and supply chain management, with applications in aerospace, military, electronics, renewable energy, high-end machine tools, and automotive industries [2][3] - The company has achieved over 2,400 research results and revised 1,076 national and industry standards since its inception [3] Financial Performance - In the first three quarters of 2025, the company reported a revenue of CNY 2.296 billion, a year-on-year increase of 27%, with core products like special and precision bearings and superhard materials contributing to over 50% growth [3][4] - Gross profit reached CNY 797 million, a 20% increase year-on-year, while net profit was CNY 245 million, up 15.4% [3][4] Business Highlights Bearing Business - The special bearing segment is a key driver of profit growth, with a 90% supply rate for key products in aerospace applications [4] - The wind power bearing business has seen significant growth, with the company developing the first domestically produced 8 MW and 18 MW wind power bearings [4] Abrasives Business - The superhard materials segment continues to grow, with the company being a pioneer in the industry since 1963 [5] - The company has developed high-efficiency processing tools for the semiconductor industry, addressing critical material needs [5] Strategic Focus and Future Outlook - The company aims to consolidate its existing advantages in bearings and abrasives while exploring new high-growth areas such as commercial aerospace and humanoid robot bearings [8] - Guoji Precision plans to maintain a dividend payout ratio of no less than 40%, with a target to rank in the top 70% of listed companies by dividend payout rate by 2024 [8][9] Governance and Investor Relations - The company emphasizes transparency in governance and investor relations, establishing a trust system that includes information disclosure and ESG governance [9] - It actively engages with investors through various channels to enhance understanding of its core value drivers and competitive advantages [9]

证券代码：002062 证券简称：宏润建设 宏润建设集团股份有限公司投资者关系活动记录表 编号：2026-02 2 | 投资者关系 | ■特定对象调研 □分析师会议 □媒体采访 □业绩说明会 | | --- | --- | | 活动类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他（请文字说明其他活动内容） | | 参与单位名称 | 中金公司—张若熙、崔力丹，中信证券—孔维实 | | 及人员姓名 | | | 时间 | 2026-01-23 | | 地点 | 宏润大厦会议室 | | 上市公司接待 | 董事会秘书薛锋、科技业务总监毛正 | | 人员姓名 | | | | 1、建筑行业业绩普遍承压，面对可能出现的新签合同量 | | | 收缩，公司是否有应对方案？ | | | 公司主营基础设施建设，其中大部分是桥梁、隧道和轨道 | | | 交通等施工技术要求较高的市政类项目。借助麻泾港枢纽工程 | | | 的中标和施工，公司也将积极拓展水利类等项目。同时，新能 | | | 源业务营收增长并实现稳定盈利，从盈利结构上助力公司应对 | | | 建筑行业的周期波动。 | | 投资者关系 | 2、新 ...

Group 1: OTC Business Development - In 2025, the company's OTC product sales revenue experienced a decline due to external environment, market factors, and internal reforms, but no severe negative impact was reported. The company aims to stabilize and optimize its marketing system and organizational structure for future growth [1] - In 2026, the company plans to enhance its brand marketing strategy focusing on "century-old brand," "authentic medicinal materials," and "intangible cultural heritage craftsmanship," while expanding into new regions, channels, and customer groups [1] Group 2: Prescription Drug Business - The prescription drug business is expected to develop steadily in 2025, focusing on cardiovascular, neurological, immunomodulatory, digestive, and gynecological fields [2] - The company is implementing a product incubation strategy for major and exclusive products, enhancing its marketing system, and building a flat sales team to improve competitiveness [2] - Sales of the product "An Gong Niu Huang Wan" have seen a decline, prompting the company to adjust its operational pace and reduce inventory to prepare for future sales recovery [2] Group 3: Stem Cell Clinical Progress - As of 2025, clinical trials for stem cell treatments have progressed, with 45 subjects enrolled for ischemic stroke treatment and 10 subjects for autoimmune pulmonary alveolar proteinosis [3] - The clinical trial for treating autism with bone marrow-derived mesenchymal stem cells was initiated on August 26, 2025, and is proceeding as planned [3] Group 4: Innovative Drug R&D - The company is developing innovative drugs, including the anticoagulant YB209 and the cyclic peptide antibiotic YB211, alongside stem cell projects [4] - By mid-2025, the YB209 project completed immunogenicity research and closed its clinical phase I, while YB211 has initiated clinical phase II trials with subject enrollment ongoing [5] Group 5: Acquisition of Jixianglong - In October 2025, the company acquired a 51.6667% stake in Jixianglong for 310 million RMB to enhance its pharmaceutical production, R&D, and business collaboration [6] - This acquisition aligns with national industrial policies and the company's strategic planning, aiming to enrich product offerings and improve overall competitiveness [6]

Group 1: Company Overview and Market Position - The company aims to achieve 50% of its total revenue from overseas markets, focusing on unconventional oil and gas resources, particularly in North America, South America, and the Middle East [3] - The management team is adjusting to enhance international market capabilities, with the new general manager bringing extensive experience from the overseas marketing system of a major competitor [3] Group 2: Product Demand and Market Trends - The demand for drilling tools is expected to stabilize as domestic oilfield production levels off, while exploration for natural gas, especially shale gas, continues to increase [2] - The core technology for shale gas development focuses on horizontal drilling and fracturing, with screw drill tools being essential for these operations [2] Group 3: Competition and Product Landscape - Major domestic competitors for screw drill tools include Tianjin Liling Petroleum Machinery Co., China National Petroleum Corporation, and Sinopec Petroleum Machinery Co. [4] - The company has successfully secured bulk orders for its new ultra-wear-resistant high-pressure acid fracturing hoses, indicating a competitive edge in the market [4] Group 4: Technological Challenges and Innovations - Key challenges in high-temperature screw drill tools include the durability of rubber components under extreme conditions, with temperatures exceeding 200°C [6] - The company has developed a specialized high-temperature material system to enhance the performance of rubber components, addressing issues like aging and sealing failures [6] Group 5: Product Lifecycle and Performance - The rated lifespan of the company's screw drill tools ranges from 100 to 600 hours, with some rotors exceeding 1,000 hours of continuous use [8]

Group 1: Automotive Business Development - The automotive electronics business is a key strategic area for the company, covering electric vehicle scenarios and extending to intelligent driving and smart cockpit applications [2] - The transition from electric to intelligent applications in the automotive sector is expected to drive rapid demand for related products, supporting the company's growth in automotive business lines [2] Group 2: AI Data Center Expansion - The company provides comprehensive component solutions for various AI server clients, leveraging its capabilities in materials, equipment, design, and manufacturing processes [3] - Orders related to AI servers are robust, and the business is projected to maintain rapid growth [3] Group 3: IoT Product Development - The company is focusing on emerging markets such as IoT, energy markets, and data centers, with ongoing efforts to promote products in these areas [3] - The IoT business is experiencing rapid development, with successful customer expansion [3] Group 4: Product Pricing and Competitiveness - The company maintains a competitive edge in electronic components, with product prices aligned with market trends [3] - Long-term partnerships with major global clients enhance the company's market position [3] Group 5: Tantalum Capacitor Business Strategy - The company has invested in R&D for tantalum capacitors, developing new products suitable for high-end consumer electronics, AI data centers, and automotive electronics [4] - The goal is to become a leading supplier in the tantalum capacitor sector, with ongoing market and customer engagement [4] Group 6: SOFC Business Development - The company is collaborating with Zhen Tai Energy to enter the solid oxide fuel cell (SOFC) market, focusing on R&D and production of new high-temperature fuel cell technologies [4] - The clean energy sector is viewed positively, with expectations for gradual revenue contributions as the industry matures [4]

Group 1: Strategic Planning and Business Development - The company aims for high-quality development by focusing on both medical and consumer goods sectors, with a strategic theme of "product leadership, excellent operations, brand enhancement, and digital empowerment" for 2026 [1] - The company plans to enhance profitability through product innovation, optimizing product structure, and improving channel management [2] - The company emphasizes long-term development and aims to return stable dividends to shareholders [2] Group 2: Investment Highlights - The core investment value is based on five aspects: broad industry space, significant brand and product advantages, stable financial status, consistent dividend policy, and a commitment to long-term sustainable development [3] - The company maintains a low debt-to-asset ratio and has robust operating cash flow, ensuring financial safety [3] Group 3: Medical Sector Growth Drivers - The medical sector's growth strategy for 2026 focuses on "product leadership" and includes three key battles: product breakthroughs, channel expansion, and integration with newly acquired companies [4] - The company plans to enhance product value and expand overseas markets while achieving revenue growth targets set by equity incentives [4] Group 4: Overseas Business Development - The company has established a solid foundation in overseas markets, including Europe, Japan, South Korea, and Southeast Asia, and aims to enhance brand sales and market presence [5] - The focus will be on clinical and academic promotion, particularly in Southeast Asia and the Middle East, with significant investments in market education [5] Group 5: Product Planning for All-Cotton Era - In 2026, the All-Cotton Era will focus on six key areas: maternal and infant care, personal care, intimate apparel, home sleep products, outdoor clothing, and light sports [6] - The strategy emphasizes the core advantages of "cotton philosophy, quality genes, and medical background" to strengthen brand recognition [6] Group 6: Retail Strategy and Store Efficiency - The All-Cotton Era plans to enhance store quality and efficiency through existing store optimization and cautious new store openings [7] - Key initiatives include upgrading store images, enhancing membership services, and embracing new retail channels for integrated online and offline experiences [8] Group 7: Dividend Policy - The company prioritizes shareholder returns, maintaining annual cash dividends, with cumulative cash dividends reaching CNY 2.88 billion by mid-2025 [9] - Future dividend levels will be assessed based on annual profits, growth potential, and strategic development plans [9] Group 8: R&D and Competitive Advantages - The company adheres to a "product leadership" strategy, focusing on innovation and high-quality product development in both medical and consumer sectors [10] - As of mid-2025, the company holds 1,109 patents in medical consumables and 701 medical product registration certificates, ensuring a leading position in the industry [10]